Growth Hormone‐Induced Stridor in a Patient With Prader–Willi Syndrome
Clinical Case Reports · 2026-03 · 14 (3)
DOI: 10.1002/ccr3.72265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 12.03.2026. Verfasst von Anthony M Saad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology- Head and Neck Surgery Rutgers New Jersey Medical School Newark New Jersey USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
While growth hormone therapy has been associated with the potential risk of upper airway obstruction and hypertrophy, it may also cause glottic or subglottic edema and stridor, even in patients without adenotonsillar tissue. Clinicians should consider medication‐induced airway changes in Prader–Willi Syndrome patients with complex airway histories to optimize management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology- Head and Neck Surgery Rutgers New Jersey Medical School Newark New Jersey USA.
- Department of Anesthesiology Newark Beth Israel Medical Center Newark New Jersey USA.
ORCID-Profile: Anthony M Saad
Zitieren
APA
Saad, A. M., Zaki, H., Menon, A., Hausdorff, M., & Manzi, B. (2026). Growth Hormone‐Induced Stridor in a Patient With Prader–Willi Syndrome. Clinical Case Reports, 14(3). https://doi.org/10.1002/ccr3.72265
Vancouver
Saad AM, Zaki H, Menon A, Hausdorff M, Manzi B. Growth Hormone‐Induced Stridor in a Patient With Prader–Willi Syndrome. Clinical Case Reports. 2026;14(3). doi:10.1002/ccr3.72265
BibTeX
@article{Saad2026,
author = {Saad, Anthony M and Zaki, Haider and Menon, Adarsh and Hausdorff, Mark and Manzi, Brian},
title = {Growth Hormone‐Induced Stridor in a Patient With Prader–Willi Syndrome},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {3},
doi = {10.1002/ccr3.72265}
}
EUVIMED